Palvella Sets November 5 Earnings Report Amid FDA Review
WAYNE, PA — Palvella Therapeutics Inc. (Nasdaq: PVLA) will report its third-quarter 2026 financial results before U.S. markets open Thursday, November 5, as the Wayne-based biotechnology company advances its development …
Palvella Sets November 5 Earnings Report Amid FDA Review Read More